Sarah Jane Tribble
KFF Health News
Washington, DC, United States
Contact Sarah
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Sarah:
Congressman Seeks to Plug ‘Shocking Loophole’ Exposed by KHN Investigation
A federal lawmaker has introduced a House bill that would close one of a laundry list of oversight gaps revealed in a recent KHN investigation of the system regulators use to ban fraudsters from billing government health programs, including Medicare and Medicaid. → Read More
Legal Questions, Inquiries Intensify Around Noble Health’s Rural Missouri Hospital Closures
A year after private equity-backed Noble Health shuttered two rural Missouri hospitals, a slew of lawsuits and state and federal investigations grind forward. Missouri Attorney General Andrew Baile… → Read More
A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relat… → Read More
KHN Investigation: The System Feds Rely On to Stop Repeat Health Fraud Is Broken
A months-long KHN examination of the system meant to bar fraudsters from Medicaid, Medicare, and other federal health programs found gaping holes and expansive gray areas through which banned indiv… → Read More
Buy and Bust: After Platinum Health Took Control of Noble Sites, All Hospital Workers Were Fired
Two Missouri towns are without operating hospitals after private equity-backed Noble Health left both facilities mired in debt, lawsuits, and federal investigations. The hospitals’ new operator, Pl… → Read More
Buy and Bust: Collapse of Private Equity-Backed Rural Hospitals Mired Employees in Medical Bills
The U.S. Labor Department investigates Noble Health after former employees of its shuttered Missouri hospitals say the private equity-backed owner took money from their paychecks and then failed to… → Read More
Rural Hospital Rescue Program Is Met With Skepticism From Administrators
A new federal rescue program that pays rural hospitals to shutter underused inpatient units and focus solely on emergency rooms and outpatient care hasn’t generated much interest yet. → Read More
Buy and Bust: When Private Equity Comes for Rural Hospitals
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk.… → Read More
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market? → Read More
As Big Pharma and Hospitals Battle Over Drug Discounts, Patients Miss Out on Millions in Benefits
The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars —… → Read More
‘No Mercy’ Bonus Episodes: More From Fort Scott, Kansas
Check out the latest bonus episodes from the award-winning “Where It Hurts” podcast. → Read More
What the Stalemate on Capitol Hill Means for Your Drug Prices
Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan. → Read More
How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters
With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting t… → Read More
The White House Says Boosters for All. Here’s What You Need to Know.
Federal officials are preparing to offer those who received Pfizer or Moderna covid vaccines a third dose in September. But the FDA and CDC are still reviewing the data for final clearance. → Read More
Rush to Boosters Sparks Confusion, Differing Recommendations
With political pressure mounting to recommend boosters, what are the experts saying about how current vaccines work and the potential benefits of another dose? → Read More
The White House Says Boosters for All. Here’s What You Need to Know.
Federal officials are preparing to offer those who received Pfizer or Moderna covid vaccines a third dose in September. But the FDA and CDC are still reviewing the data for final clearance. → Read More
Pfizer CEO to Public: Just Trust Us on the Covid Booster
As pharmaceutical companies declare a need for boosters, scientists and doctors emphasize there’s no proof yet. → Read More
Pfizer CEO to Public: Just Trust Us on the Covid Booster
As pharmaceutical companies declare a need for boosters, scientists and doctors emphasize there’s no proof yet. → Read More
Health Experts Say Expanding Vaccine Access Requires More Than Patent Waivers
In the best-case scenario, sharing patents is only a tiny step in the vastly complex work of making a COVID vaccine. → Read More
This Small Canadian Drugmaker Wants to Make J&J Vaccines for Poor Nations. It Needs More Than a Patent Waiver.
All agree that covid vaccines are urgently needed to stop the pandemic, but simply waiving patents fails to provide technological know-how and address supply chain challenges. → Read More